Adipose tissue as a target for second-generation (atypical) antipsychotics: A molecular view

Autor: Vitor Ferreira, Diana Grajales, Ángela M. Valverde
Přispěvatelé: Ministerio de Ciencia, Innovación y Universidades (España), Agencia Estatal de Investigación (España), Comunidad de Madrid, European Commission, Instituto de Salud Carlos III
Rok vydání: 2020
Předmět:
Zdroj: Biblos-e Archivo: Repositorio Institucional de la UAM
Universidad Autónoma de Madrid
Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids
Biblos-e Archivo. Repositorio Institucional de la UAM
instname
Digital.CSIC. Repositorio Institucional del CSIC
ISSN: 1388-1981
DOI: 10.1016/j.bbalip.2019.158534
Popis: Schizophrenia is a neuropsychiatric disorder that chronically affects 21 million people worldwide. Second-generation antipsychotics (SGAs) are the cornerstone in the management of schizophrenia. However, despite their efficacy in counteracting both positive and negative symptomatology of schizophrenia, recent clinical observations have described an increase in the prevalence of metabolic disturbances in patients treated with SGAs, including abnormal weight gain, hyperglycemia and dyslipidemia. While the molecular mechanisms responsible for these side-effects remain poorly understood, increasing evidence points to a link between SGAs and adipose tissue depots of white, brown and beige adipocytes. In this review, we survey the present knowledge in this area, with a particular focus on the molecular aspects of adipocyte biology including differentiation, lipid metabolism, thermogenic function and the browning/beiging process.
This work was funded by H2020 Marie Skłodowska-Curie ActionsITN-TREATMENT (Grant Agreement 721236, European Commission). We also acknowledge grants RTI2018-094052-B-100 (MICINN/FEDER, Spain), S2017/BMD-3684 MOIR2-CM (Comunidad de Madrid, Spain) and CIBERdem (ISCIII, Spain).
Databáze: OpenAIRE